Pediatric Brain Tumors Market to Expect Impressive Growth from 2019-2032 – DelveInsight | Key Companies – Novartis, Oncoceutics, Ziopharm, Cellectar Biosciences, Laminar Pharma, and Moleculin Biotech

July 03 15:10 2022
Pediatric Brain Tumors Market to Expect Impressive Growth from 2019-2032 – DelveInsight | Key Companies – Novartis, Oncoceutics, Ziopharm, Cellectar Biosciences, Laminar Pharma, and Moleculin Biotech
Pediatric Brain Tumors Market

DelveInsight’s “Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Pediatric Brain Tumors Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).


The Pediatric Brain Tumors market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 


Pediatric Brain Tumors: An Overview


Pediatric central nervous system (CNS) tumors are the second most common childhood malignancy and the most common solid tumor in children. Approximately 4,000 children and adolescents in the US are diagnosed with primary brain tumors each year. Primary brain tumors start in the brain and generally do not spread outside the brain tissue.

Combinations of surgery, radiation therapy, and chemotherapy are mainly used for the treatment of pediatric brain tumors.


Pediatric Brain Tumors Market Key Facts

  • According to the American Cancer Society, brain and spinal cord tumors are the second most common cancers in children (after leukemia). They account for about 1 out of 4 childhood cancers. More than 4,000 brain and spinal cord tumors are diagnosed each year in children and teens. The incidence rate (number of tumors per 100,000 children) has not changed much in recent years.
  • In children, the incidence of brain cancer is approximately 4.84 per 100,000, according to the National Cancer Institute.
  • As per Cancer.Net, about 3,540 children under the age of 15 were likely to be diagnosed with a brain or CNS tumor in 2020.


Pediatric Brain Tumors Market

  • Pediatric Brain Tumors market size is expected to increase during the forecast period owing to the rise in the number of incident cases in the 7MM, estimates DelveInsight.
  • The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Pediatric Brain Tumors market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
  • The report gives a thorough detail of the Pediatric Brain Tumors market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.


Pediatric Brain Tumors Epidemiology


The epidemiology section covers insights into the historical and current Pediatric Brain Tumors patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.


Pediatric Brain Tumors Epidemiology Segmentation

  • Total Incident cases of Pediatric brain tumors
  • Gender-specific Incident cases of Pediatric brain tumors
  • Diagnosed and Treatable cases of Pediatric brain tumors
  • Type-specific Incident cases of Pediatric brain tumors


Pediatric Brain Tumors Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pediatric Brain Tumors market or expected to get launched in the market during the study period. The analysis covers Pediatric Brain Tumors market uptake by drugs, patient uptake by therapies, and sales of each drug. 


Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.


The report also covers the Pediatric Brain Tumors Pipeline Development Activities and provides valuable insights about different therapeutic candidates in various stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.



Request for Sample PDF Report –


Pediatric Brain Tumors Therapeutics Analysis

The Pediatric brain tumors market dynamics is anticipated to change in the coming years owing to the improvement in healthcare spending across the world.

Currently, there are several potential players with their promising pipeline therapies in the early and mid stages of clinical development.


Some of the key Companies in the Pediatric Brain Tumors Market Includes:

  • Oncoceutics
  • Novartis
  • Ziopharm
  • Laminar Pharmaceuticals
  • Cellectar Biosciences
  • Moleculin Biotech

And many others.


Pediatric Brain Tumors Therapies covered in the report include:

  • Everolimus
  • LP561A1
  • Ad-RTS-hIL-12 + veledimex
  • ONC201
  • CLR-131
  • WP1066

And many more.


Get More Detailed Insights Into the Emerging Therapies & Key Companies –  Pediatric Brain Tumors Therapies and Companies


Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Pediatric Brain Tumors Competitive Intelligence Analysis

4. Pediatric Brain Tumors Market Overview at a Glance

5. Pediatric Brain Tumors Disease Background and Overview

6. Pediatric Brain Tumors Patient Journey

7. Pediatric Brain Tumors Epidemiology and Patient Population

8. Pediatric Brain Tumors Treatment Algorithm, Current Treatment, and Medical Practices

9. Pediatric Brain Tumors Unmet Needs

10. Key Endpoints of Pediatric Brain Tumors Treatment

11. Pediatric Brain Tumors Marketed Products

12. Pediatric Brain Tumors Emerging Therapies

13. Pediatric Brain Tumors Seven Major Market Analysis

14. Attribute Analysis

15. Pediatric Brain Tumors Market Outlook (7 major markets)

16. Pediatric Brain Tumors Access and Reimbursement Overview

17. KOL Views on the Pediatric Brain Tumors Market.

18. Pediatric Brain Tumors Market Drivers

19. Pediatric Brain Tumors Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


Download Sample PDF Report –


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.


Other Latest Reports By DelveInsight

Global Kinase Inhibitor in Autoimmune Diseases Market

Global Kinase Inhibitor in Autoimmune Diseases Market” report delivers an in-depth understanding of the Global Kinase Inhibitor in Autoimmune Diseases, historical and forecasted epidemiology as well as the Global Kinase Inhibitor in Autoimmune Diseases market size, share, and trends in the 7MM.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States